Who Paid My Doc
A randomized, multicenter, open-label trial comparing the effectiveness of an "inclisiran first" implementation strategy to usual care on LDL cholesterol (LDL-C) in patients with atherosclerotic cardiovascular disease and elevated LDL-C (70 mg/dL) despite receiving maximally tolerated statin therapy (VICTORION-INITIATE)
Research payments
$3,352,238
Through program year 2024, $3,352,238 in research payments was reported against A randomized, multicenter, open-label trial comparing the effectiveness of an "inclisiran first" implementation strategy to usual care on LDL cholesterol (LDL-C) in patients with atherosclerotic cardiovascular disease and elevated LDL-C (70 mg/dL) despite receiving maximally tolerated statin therapy (VICTORION-INITIATE), across 144 payments, paid by Novartis Pharmaceuticals Corporation.
- Paid by
- Novartis Pharmaceuticals Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $976,459 | 54 |
| 2023 | Research | $2,375,778 | 90 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Veena Watwe Houston, TX Named on 4 payments
- Venkatesh Nadar Camp Hill, PA Named on 4 payments
- Nasir Rahmatullah Kissimmee, FL Named on 4 payments
- Aditya Samal Houston, TX Named on 4 payments
- Justin Gainor Boston, MA Named on 4 payments
- Leandro Slipczuk Bronx, NY Named on 4 payments
- Parveen Garg Los Angeles, CA Named on 4 payments
- Jasjit Walia Elizabeth, NJ Named on 4 payments
- Michael Koren Jacksonville, FL Named on 4 payments
- Abiodun Ishola Edgewood, KY Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.